Osel, Inc. Company Profile

08:19 EDT 23rd June 2018 | BioPortfolio

Osel, Inc., a privately held biotechnology company, is focused on the development and commercialization of a portfolio of Live Biotherapeutic Products (LBPs) that prevent or treat medical conditions resulting from a disruption of the human microbiome. The company is a pioneer in the field of LBPs. In 2003, Osel became one of the first companies to receive U.S. Food and Drug Administration authorization to test a commensal bacterium as a live bacterial therapeutic. The company’s proprietary approach identifies differences between healthy and disease-related microbiomes and leverages beneficial microbes to treat problematic disruptions or dysbioses. Osel’s approach repopulates the disrupted microbiome with beneficial bacteria that help restore a healthy and protective microbiota.

News Articles [3 Associated News Articles listed on BioPortfolio]

Osel’s LACTIN-V Enters Clinical Study to Improve the Success Rate of IVF in Women With Imbalanced Vaginal Microbiomes

Study based on findings that women with abnormal vaginal microbiota had only 9% success of pregnancy with IVF versus 44% for those with healthy vaginal bacteria levels ...

Global and Europe Human Micobiome Market Status and Future Forecast 20132023 [Report Updated: 10012018] Prices from USD $3500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

20152023 World Human Micobiome Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 11122017] Prices from USD $2800

SummaryThe Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archae...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Osel Inc.

Osel is the leading company in the emerging field of Bacterio-Therapeutics. Our business is based upon commercializing pharmaceutical products utilizing naturally occurring bacteria in the maintenance...

Osel, Inc.

Osel, Inc., a privately held biotechnology company, is focused on the development and commercialization of a portfolio of Live Biotherapeutic Products (LBPs) that prevent or treat...

More Information about "Osel, Inc." on BioPortfolio

We have published hundreds of Osel, Inc. news stories on BioPortfolio along with dozens of Osel, Inc. Clinical Trials and PubMed Articles about Osel, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Osel, Inc. Companies in our database. You can also find out about relevant Osel, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Corporate Database Quicklinks

Searches Linking to this Company Record